Table 2 Characteristics of venous thromboembolism in the study sample (N = 51)
Early VTE | Late VTE | Total VTE | ||
|---|---|---|---|---|
N (%, of all VTE) | N (%, of all VTE) | N (%, of all VTE) | % (of all patients) | |
Site of VTE: | ||||
DVT | 3 (5.9) | 4 (7.8) | 7 (13.7) | 3.2 |
PE | 5 (9.8) | 8 (15.7) | 13 (25.5) | 6.0 |
VVT | 12 (23.5) | 14 (27.5) | 26 (51) | 12.0 |
PE + DVT | 3 (5.9) | 0 (0) | 3 (5.9) | 1.4 |
CVC related | 0 (0) | 2 (3.9) | 2 (3.9) | 0.9 |
Total | 23 (45.1) | 28 (54.9) | 51 (100) | 23.6 |
Symptoms: | ||||
Symptomatic | 7 (13.7) | 8 (15.7) | 15 (29.4) | 6.9 |
Asymptomatic | 16 (31.4) | 20 (39.2) | 36 (70.6) | 16.7 |
Total | 23 (45.1) | 28 (54.9) | 51 (100) | 23.6 |
Coagulation | ||||
Yes | 9 (17.6) | 6 (11.8) | 15 (29.4) | 6.9 |
No | 14 (27.5) | 22 (43.1) | 36 (70.6) | 16.7 |
Total | 23 (45.1) | 28 (54.9) | 51 (100) | 23.6 |
Time from the advanced pancreatic cancer to VTE diagnosis (months) | ||||
Median (range) | 2.2 (1.9–2.7) | |||
Overall survival from VTE to death (months) | ||||
Median (range) | 2.4 (1.5–3.3) | |||